explore -WSS

explore

author：focus 2025-09-14 11:51:28 - browse：5391

PORTRAIT of Michelle Monje smiling with trees in the background. -- health coverage from STAT. — New research led by Stanford neuro-oncologist Michelle Monje shines light on the electrochemical signaling pathway between neurons and cancer cells. Courtesy MacArthur Foundation

The idea that cancer can hijack brain plasticity — subverting supple connections in the healthy brain that ordinarily lead to learning and memory formation — is gaining traction.

First reported in Cell in 2015, research led by Stanford neuro-oncologist Michelle Monje showed that active nerve cells could promote the growth of high-grade gliomas, a form of brain cancer with a poor prognosis. Four years later, her lab revealed in a Nature paper that synapses between these neurons and gliomas spurred tumor growth, and last year, the team demonstrated how these same synapses revved up glioblastoma’s spread.

There are still many questions about precisely how this process unfolds, and it’s too soon to say how solutions might be reached. But in a new paper published in Nature on Wednesday, Monje’s team solves another part of the puzzle, shining light on the electrochemical signaling pathway between neurons and cancer cells.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： 5 ways to address the shortage of health care workers

focus

WSS

Medicare Advantage isn’t working — for anyone

Quicker fix for pulse oximeters urged during FDA public meeting

Readout Newsletter: Vertex, Biogen's Aduhelm, and Bristol updates

Neuroscience renaissance leads to new crop of psychiatric drugs

Woodcock on FDA’s accelerated approval and her next chapter

NEJM study measures Covid brain fog, impact on IQ

focus

explore

hotspot

Sports medicine is finally prioritizing gender equality

FDA drug safety: Singulair case shows systemic surveillance flaws

Novavax promises a turnaround & Lilly roils the obesity market

Apple Vision Pro: A first look at health apps on the new VR headset

Anesthesiologist group: stop taking Ozempic before surgery

Even great ERs can’t make up for American health disparities

Vertigo drug brings hope for rare neuron disorder, Niemann

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

A $475,000 price tag for a new cancer drug: crazy or meh?

hotspot

FDA drug safety: Singulair case shows systemic surveillance flaws

Readout Newsletter: Beam, Prozac, "TechBio" and more

Readout Newsletter: Beam, Prozac, "TechBio" and more

Mifepristone protocols being wielded by pill's opponents in Supreme Court case

Some dementia cases could be undiagnosed liver disease

The lessons of Aduhelm, an Alzheimer's drug that was not to be

focus

explore

focus

hotspot